Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kristen K. Flaharty"'
Publikováno v:
Supportive Care in Cancer
Purpose The use of serotonin type 3 (5-HT3) receptor antagonists (RAs) in the prevention of nausea and vomiting caused by emetogenic chemotherapy is part of a comprehensive management strategy for patients undergoing chemotherapy. Electrocardiographi
Publikováno v:
Insight (American Society of Ophthalmic Registered Nurses). 39(3)
Publikováno v:
American Journal of Hematology. 36:105-110
The metabolic fate of erythropoietin (EPO) remains unknown. Urinary excretion does not appear to play a major role and liver catabolism has been shown to occur only after terminal sugars on the hormone have been removed. However, it has been proposed
Autor:
Kristen K. Flaharty
Publikováno v:
Journal of Pharmaceutical Care in Pain & Symptom Control. 1:119-121
Autor:
Kristen K. Flaharty, Thorir D Bjornsson, Allan Erslev, John J. Whalen, Edward M Morris, Peter H Vlasses, Jaime Caro
Publikováno v:
Clinical pharmacology and therapeutics. 47(5)
To assess the safety, pharmacokinetics, and erythropoietic responses to human recombinant erythropoietin (epoetin beta), single intravenous doses (10, 50, 150, and 500 IU/kg) were administered at monthly intervals to 16 healthy subjects in a two-pane
Publikováno v:
American Journal of Health-System Pharmacy. 46:2553-2556
Publikováno v:
Pharmacotherapy. 9(1)
Amiodarone has been reported to cause asymptomatic increases in liver function tests in 15 — 55% of patients. Clinically apparent, symptomatic hepatic disease occurs less frequently, but patients have been reported to have hepatomegaly, jaundice, c